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1 Introduction
The permeability of the placenta for parathy-
roid hormone (PTH) was first postulated by
MEINERT 1898 [19]. He and later on BRONSKY
[7] reported relief of tetany during pregnancy
in women with hypoparathyroidism prior to
conception. The authors proposed that the re-
lief of tetany was by transfer of fetal PTH to
the mothers.
The permeability of the placenta for PTH was
studied in vivo in several animal experiments
[9, 11, 13, 16, 18, 22, 30]. PTH transfer was
observed, but the transfer was inconsistent and
the amounts of transferred hormone were very
small. The authors concluded that PTH does
not cross the placenta in either direction.
Recently we have reported that PTH (amino
acids 35 — 84) traverses the human placenta at
term in both directions. These effects were stud-
ied in an in vitro placenta perfusion model [4].
The transferred PTH quantities (up to 5% of
the perfused PTH) were determined radioim-
munologically and consequently it was not pos-
sible to exclude that only PTH fragments or
metabolites were transferred.
In this study we have investigated the placental
transfer of three PTH fragments in vitro. The
perfused and transferred fragments were identi-
fied by three different physiochemical methods.
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2 Materials and methods
2.1 Placental perfusion
Placentae at term were obtained immediately
after delivery. A cotyledon approximately
3—4 cm as preparated for perfusion according
to the method and the perfusion model devel-
oped by HENRICHS and WOLF [14], which was
a modification of the model of SCHNEIDER [27].
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PTH extract was infused into the fetal artery
(feto-maternal transfer) for 20 minutes. Perfu-
sate samples from the maternal side (MS) and
the fetal vein (FV) were taken at intervals of 3
and 5 minutes over a period of 40 min after
the start of perfusion. Complete separation of
samples from the maternal and fetal sides was
proved by dextranblue added to the perfusate.
Furthermore, PTH extract was infused into the
intravillous space for 20 min. Perfusate samples
from fetal and maternal vein were taken as
above. The PTH fragments assayed for the
perfusion were: 125I-labelled (*) and nonlabelled
bovine C-terminal (amino acids 35 — 84) frag-
vment (Institut National des Radioelements, Bel-
gium), 125I-labelled (*) and nonlabelled synthet-
ic middle C-terminal (44 — 68) fragment (Paesel,
Germany), and 125I-labelled (*) synthetic
human C-terminal (amino acids 65 — 84) frag-
ment (Bachern, Switzerland). The activities of
the labelled fragments were 1 μΟί for each ex-
periment.
The transfer of the labelled fragments was
determined by counting the activity in the sam-
ples collected at the opposite site. The transfer
of nonlabelled hormone was determined by ra-
dioimmunoassays (35 — 84: Institut National
des Radioelements, Belgium, 44—68: Paesel,
Germany).
The identification of fragments was achieved as
follows:
a) High-pressure-liquid chromatography
(HPLC) (Waters Inc). Synchropak RPR
10 μ, 100 A in 250 4.6mm stainless-steel
columns (Bischoff, Germany) were used.
Separation was carried out at 20 °C, with
0.1 m phosphate buffer (pH 2.1) as primary
solvent and acetonitril as organic modifier
at constant flow rate of 1 ml/min and
220 nm UV adsorbance. The fractions were
collected and the radioactivity of each meas-
ured in the gamma counter.
b) Preparative-flat-bed electrofocusing
(PEGG) was performed in a granulated gel
(5ml 40% Servalyt pH 2-11,5 ml sample,
90 ml distilled water). The separated zones
were collected and their activity measured
in the gamma counter.
c) Gel filtration (GF). For the gel filtration of
sephadex columns G—25 900 16 mm (Phar-
macia, Sweden) were used. The flow rate
was 1.0 ml/min at 20 °C in phosphate buffer
pH 7.5. Fractions were collected at 2ml.
The activity in the collected fractions was
measured. Dextranblue, cytochrome C and
vitamin B were added as calibrating sub-
stances to each filtration.
2.2 RIA for PTH
The concentrations of PTH fragments 35—84
were measured by RIA of the C-terminal. The
standard was bovine PTH, the antiserum was
a rabbit antiserum directed against the C-ter-
minal part (amino acids 35 — 84) of the mole-
cule. The standard curve covers the range
0.3 ng/ml —12,5 ng/ml. The intra- and interas-
say coefficients of variation were 7.2% and
10.2%. RIA for PTH 44-68:
The standard was synthetic PTH, the antibody
was prepared in the goat against the amino
acids 44—68 part of the hormone. The lower
limit of sensitivity was 0.05 ng/ml. The intraas-
say coefficient of variation »was 11.2%.
2.3 Patients
Forty healthy pregnant women who were ad-
mitted to the University Maternity Hospital for
delivery were studied. Informed consent was
obtained from each. All infants were born at
term by spontaneous vaginal delivery. Forty
blood samples were obtained by venipuncture
from mothers at delivery and from the umbili-
cal cord by separate catheterization of the um-
bilical cord vein and artery. After centrifugation
plasma samples were frozen at — 20 °C until
analyzed. The samples were collected from Oc-
tober 1981 through February 1982. Plasma
samples of 169 normal adult volunteers (87
women and 82 men) ranging in age from 20 to
50 years were studied for reference.
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2.4 Statistical methods
Results were expressed as median and range.
Data were statistically evaluated using the Wil-
coxon test for paired samples and Student't-
test for comparison of individual values. Corre-
lations (r) were tested by linear regression
analysis.
3 Results
The transfer of 125I-labelled or nonlabelled PTH
fragments was detected after 3 minutes of per-
fusion. The concentrations measured by RIA
and/or counting of the radioactivity (CPM)
rose during the perfusion up to 5% of the
perfused concentration (figure 1). The retention
times (rt) and isoelectric points (IP) of the
perfused and transferred 125I-labelled PTH frag-
ments, determined by GF, HPLC and PEGG
respectively, were identical.
On GF analysis the eluted labelled PTH frag-
ments (35-84)*, (44-68)* and (65-84)* with
molecular weights (MWt) of 6300, 3250 and
2450 respectively, showed positions which were
consistent with the calibrating substances (dex-
tranblue, cytochrom C and vitamin B with
MWt of 2000000, 12300 and 1355, respective-
ly). The results of the different separation
methods for three fragments are given in figure
2.
We observed up to a 67% degradation of the
PTH hormone during the passage of the
placenta (from fetal to maternal side and vice
versa) (figure 3).
The median and ranges for plasma PTH (amino
acids 35 — 84) of maternal venous, umbilical
cord vessel samples and adult venous plasma
samples studied as controls are demonstrated
in the table I. PTH was detected in all 40
maternal and umbilical cord vessel plasma sam-
ples. The umbilical venous PTH concentrations
were significantly lower than the arterial
(P < 0.001). The median of the arterial and
venous umbilical samples differed about 0.2 ng/
ml. The fetal venous PTH values were signifi-
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Figure 1. Feto maternal transfer of 125I-labelled (35-84, 44-68 and 65-84) and non labelled (35-84 and 44-68)
fragments. Perfused fragments 35-84 «nn r, 44-68 Ο Ο, 65 —84 ΔΔ. Transferred fragments: 35 — 84 **, 44—68
and 65-84 A A.
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Figure 2. Elution profiles after GF, PEGG and HPLC of I-labelled PTH fragments amino acids (35-84)*, (44-68)*
and (65 — 84)*. The arrows indicate the retention times of substances added to each measurement as calibrating
substances.
GF (gelfiltration): fetal vein: arrows 1. dextranblue, 2. cytochrom C, 3. PTH standards and 4. vitamin B12.
Maternal side: arrows 1. cytochrome C, 2. PTH standards and 3. vitamin B12. PEGG (preparative flat bed
electrofocusion): both fetal and maternal sides: arrow 1. PTH standard. HPLC (high-pressure liquid chromatogra-
phy): both fetal and maternal side arrows 1 to 3 PTH standards 35 — 84, 44—68 and 65 — 84 respectively.
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Figure 3. Degradation of PTH (amino acids 35 — 84) during passage from the placental fetal artery to the fetal vein
and through the intervillous space to the maternal vein.
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Table L Concentrations of parathyroid hormone (PTH) (amino acids 35 — 84) in maternal venous plasma at delivery,
plasma of umbilical cord vessels and in venous blood of normal adult voluntees.
median
PTH (ng/ml)
range
Maternal plasma
Umbilical artery
Umbilical vein (n = 40)
Correlation between maternal and umbilical cord vein concentrations
P-values of umbilical arterial-venous difference
Control values of adults (n = 169)
1.8
1.4
1.2
s r = 0.682Ρ < 0.001
Ρ < 0.001
0.5-3.4
0.7-3.3
0.7-3.0
0.5-2.9
cantly lower than the maternal values at deliv-
ery (P < 0.001). There was a significant corre-
lation between maternal and venous cord plas-
ma PTH (r = 0.682, P < 0.001) (figure 4).
PTH ng/ml
uabilicel cord vein
3-1
2-
1-
1 2
PTH ng/mf maternal vein
Figure 4. Correlation between PTH (amino acids
35—84) concentrations in maternal and venous cord
plasma.
4 Discussion
The permeability of mammalian placenta for
PTH has been studied in vivo by different inves-
tigators. No transfer was found in animal ex-
periments by HOSKIN et al [16], SMITH et al [30],
LEHRMANN et al [18], CARE et al [9], FLEISCHMAN
et al [13], NORTHROP et al [22], and ERENBERG
et al [11]. In contrast, when the data of SMITH
et al [30] and NORTHROP et al [22] are recon-
sidered, it is evident that in some experiments
the PTH concentrations in the fetus increased
after injection of PTH into the pregnant animal
and vice versa. However, the amounts of trans-
ferred hormone were very small and inconsis-
tent and the authors concluded that PTH did
not cross the placental barrier in either direc-
tion.
Intact PTH (amino acids 1 — 84) has a molecu-
lar weight of above 10000. In the circulation,
it is rapidly cleaved through receptors in the
periphery. Circulating PTH, represents a heter-
ogenous mixture of polypeptides with different
molecular weights [8]. The low molecular
weight fragments may traverse the placenta [28]
easier than the high molecular fragments. In
our studies we have demonstrated placental
transfer of three different PTH fragments with
molecular weights between 1500 and 7000
(figure 2).
Conversely, we have also observed up to 67%
PTH (amino acids 35 — 84) degradation during
the passage through the placenta. This could
explain the low amount of PTH transfer in the
previously described animal experiments:
Placental transfer is dependent upon various
factors, such as fat solubility, degree of ioniza-
tion, possible existence of a transport mechan-
ism and the PTH transfer also from calcium
J. Perinat. Med. 14 (1986)
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homeostasis. All these variables are not present
under our experimental conditions.
This hypothesis of the PTH transfer is in agree-
ment with the measurements of PTH in plasma
of maternal and umbilical cord vessels. We de-
tected immunoassayable PTH in all maternal
venous and arterial and venous umbilical cord
plasma samples with a highly significant corre-
lation between maternal and umbilical cord
venous plasma concentrations (figure 4) [3].
All arterial and venous cord umbilical plasma
values were lower than the maternal PTH val-
ues but within the range of normal adult values.
These results are in accordance with the data
\ofScHEDEWiE et al [26], LEQUIN et al [17], TSANG
et al [31], WATNEY et al [32], and PITKIN et al
[23]. On the contrary, FANCONI et al [12], DAVID
et al [10], ROOT et al [25], FLEISCHMANN et al
[13], REITZ et al [24], HILLMANN et al [15], and
WIELAND et al [33] either could not detect PTH
in cord blood or observed only very low con-
centrations.
The discrepancies of data from different investi-
gators could be explained by the use of different
antisera. The specific antisera in the radioim-
munosassy determine different PTH fragments
[2]. The lack of a PTH standard of human
origin, the immunological differences between
species, the fact that genuine glandular hor-
mone is immunologically different from
secreted hormone, and the lack of international
standard material all may account for the diver-
gence of results.
In this study we observed significantly higher
PTH levels in the umbilical cord artery than in
the vein. NORRIS [21], MOSCA [20], and ANAST
[1] demonstrated that the fetal parathyroid
glands develop during the first three embryonic
months. SCOTHORN [29] showed that parathy-
roid function in the human fetus may be present
as early as twelve to thirteen weeks of gestation.
In accordance with these authors, our results
prove that the fetus at term secretes PTH into
its plasma.
In summary the present study demonstrates the
placental transfer of different PTH fragments
in an in vitro perfusion model. The perfused
and transferred fragments were identical. It was
also observed, that human placenta, similar to
the kidney and liver [6], degraded the hormone.
The measured PTH concentrations in the um-
bilical cord vessels plasma as well as the signifi-
cant correlation between PTH values in ma-
ternal and umbilical cord venous plasma sup-
ported the in vitro findings and led to the
conclusion that PTH transfer also occurs in
vivo.
The permeability of the human placenta for
PTH fragments and its capacity to degrade the
hormone suggests the importance of this organ
in the calcium homeostasis during pregnancy.
Summary
We investigated the in vitro transfer of three parathyroid
hormone (PTH) fragments (amino acids 35 —84, 44—68
and 65 — 84) through human placenta at term. The
perfused and transferred fragments were measured ra-
dioimmunologically and identified by three different
methods: high-pressure-liquid chromatography (HPLC),
preparative flat-bed electrofocussing (PEGG), and gel
filtration (GF). The study demonstrated that PTH frag-
ments traverse the human placenta. The transferred and
perfused fragments were identical. We observed a signifi-
cant degradation of the perfused hormone during the
passage through the placenta in both fetal and maternal
directions.
In addition, we measured the PTH concentrations on
forty samples of maternal and umbilical cord artery
and vein plasma obtained immediately after delivery. A
highly significant correlation of PTH concentrations in
the maternal and umbilical cord vessels was observed.
These findings support the contention that human
placenta at term is permeable for PTH fragments.
Keywords: Degradation, parathyroid hormone, placenta, transfer.
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Zusammenfassung
Plazentarer Transport von Parathormon
Die Durchlässigkeit der menschlichen Plazenta wurde
mit Hilfe einer in vitro Perfusion untersucht. Dabei
konnte bei Perfusionen mit PTH Fragmenten (35 — 84),
(44—68) und (65 — 84) ein Transfer nachgewiesen wer-
den. Durch die Auftrennung des maternal venösen und
fetal venösen Perfusats mittels Gelchromatographie,
isoelektrischer Fokussierung und Reversed-Phase Chro-
matographie konnte gezeigt werden, daß die PTH-Frag-
mente größtenteils unverändert durch die Plazenta-
schranke hindurchgelangten. Bei der Durchführung der
plazentaren Perfusion wurde eine Abnahme der Hor-
monkonzentration beobachtet.
Bei 40 gesunden Müttern wurde nach der Entbindung
Parathormon im peripheren Venenblut sowie im Blut
der Nabelschnurarterie und -vene des Kindes bestimmt.
Zwischen den Parathormon-Konzentrationen im Blut
der Mutter und denen der Nabelschnurvene bestand eine
signifikante Korrelation. Auch dies ist mit der Annahme
eines diaplazentaren Transports von humanen Parathor-
mon in vivo vereinbar.
Schlüsselwörter: Abbau, Parathormon, Plazenta, Transport.
Resume
Transfer! placentaire de l'hormone parathyroidienne
Nous avons etudie le transfert in vitro de 3 fragments de
l'hormone parathyro'idienne ou P. T. H. (acides amines
35 — 84, 44—68, et 65 — 84) ä travers le placenta humain
ä terme. Les mesures des fragments perfuses et transferes
etaient effectuees par radioimmunologie et leurs identifi-
cations realisees par trois methodes differentes: Chroma-
tographie en phase liquide a haute pression (H. P. L. C.),
electroconcentration preparatoire (P. E. G. G.) et filtra-
tion sur GEL (G. F.). Les resultats montrent que les
fragments de P. T. H. traversent le placenta humain. Les
fragments transferes et ceux perfuses sont identiques.
Nous avons egalement observe une degradation signifi-
cative de l'hormone perfusee au cours du passage placen-
taire que ce soit en direction du foetus ou de la mere.
En outre, nous avons mesure les concentrations de
P. T. H. dans quarante echantillons de plasma preleves
immediatement apres Faccouchement chez la mere et
au niveau de Fartere et de la veine ombilicales. Une
correlation hautement significative a 6te observee entre
les concentrations de P. T. H. maternelles et dans les
vaisseaux ombilicaux. Ces donnees appuient Faffirma-
tion que le placenta humain ä terme est permeable pour
les fragments de P. T. H.
Mots-cles: Degradation, hormone parathyro'idienne, placenta, transfert.
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